Condition: Aortic Valve Stenosis · Sponsor: Shanghai NewMed Medical Co., Ltd.
The purpose of this clinical trial is to evaluate the safety and efficacy of the Prizvalve Pro™ transcatheter aortic valve system in the treatment of patients with severe aortic stenosis who are at high risk of surgery or who are not suitable for surgery.
This description comes directly from the study's public registry record.
Chunyang Wang · (86)-21-20788668 · wang_chunyang@newmed.cn
Xuyang Xie · (86)-21-20788668
Always discuss trial participation with your own doctor first.
| Shanghai NewMed Medical Co., Ltd. | Shanghai, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05864456